Detailed Information on Publication Record
2003
Pramipexole and pergolide in the treatment of depression in Parkinson's disease:a national multicentre prospective randomized study.
REKTOROVÁ, Irena, Ivan REKTOR, Martin BAREŠ, V. DOSTÁL, Edvard EHLER et. al.Basic information
Original name
Pramipexole and pergolide in the treatment of depression in Parkinson's disease:a national multicentre prospective randomized study.
Authors
REKTOROVÁ, Irena (203 Czech Republic, guarantor), Ivan REKTOR (203 Czech Republic), Martin BAREŠ (203 Czech Republic), V. DOSTÁL (203 Czech Republic), Edvard EHLER (203 Czech Republic), Zuzana FANFRDLOVÁ (203 Czech Republic), Jiří FIEDLER (203 Czech Republic), Hana KLAJBLOVÁ (203 Czech Republic), P. KULIŠŤÁK (203 Czech Republic), Pavel RESSNER (203 Czech Republic), J. SVÁTOVÁ (203 Czech Republic), Karel URBÁNEK (203 Czech Republic) and Jana VELÍSKOVÁ (203 Czech Republic)
Edition
European Journal of Neurology, Oxford, Blackwell Science, 2003, 1351-5101
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.000
RIV identification code
RIV/00216224:14110/03:00009457
Organization unit
Faculty of Medicine
UT WoS
000183687100009
Keywords in English
depression;dopamine receptor agonists;Parkinson's disease
Změněno: 26/6/2009 15:58, prof. MUDr. Irena Rektorová, Ph.D.
Abstract
V originále
An 8-month multicentre prospective randomized study aimed at comparing the effects of dopamine receptor agonists pramipexole as add-on to L-dopa therapyon depression in 41 non-demented patients suffering from both mild or moderate depression and advanced Parkinson's disease.